976500745
News

Van Eyk sale 'won't change research product'

Wednesday 10th of April 2013

The 38% stake was sold for A$13.3 million to Merrick Capital, although PGC will retain a convertible note holding.

Van Eyk chief executive Mark Thomas said it would not make a difference to the operation of Van Eyk. “Our product and services offering will not change as a result of the sale, nor will our management or strategic direction. As a business, we continue to operate on the same...

Want to read the full article?

Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.

You will also be able to comment on articles on Good Returns.